The number of people with susceptibility test result for rifampicin in Slovakia
Slovakia: The number of people with susceptibility test result for rifampicin was 65 in 2021. ▼ Falling
Latest (2021)
65
Change on year
up 27.5%
World rank
116th
of 155 countries
All-time high
116
in 2018
All-time low
51
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Slovakia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Slovakia recorded 65 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 27.5% on the previous year and down 33.7% over five years.
Slovakia ranks 116th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Slovakia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 98 | — |
| 2018 | 116 | +18.4% |
| 2019 | 79 | -31.9% |
| 2020 | 51 | -35.4% |
| 2021 | 65 | +27.5% |
Slovakia compared with similar countries
- Slovakia's 65 is below the median for high income countries, which is 142, 46% of the median. (61 countries reporting)
- Slovakia's 65 is below the median for Europe & Central Asia, which is 229.5, 28% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 97.67 | 79 | 116 | 3 |
| 2020s | 58 | 51 | 65 | 2 |
Countries ranked near Slovakia
More health data for Slovakia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,433 deaths per 1,000 people (2090)
- Number of infants who die before age 1 28 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.48 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0234 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.33 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Slovakia?
- The number of people with susceptibility test result for rifampicin in Slovakia was 65 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Slovakia?
- The highest recorded value was 116 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Slovakia?
- The lowest recorded value was 51 in 2020.
- How does Slovakia rank for the number of people with susceptibility test result for rifampicin?
- Slovakia ranks 116th out of 155 countries with data for 2021.
- Where does this Slovakia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).